Literature DB >> 17217256

Cancer/testis (CT) antigens are expressed in fetal ovary.

Peter T Nelson1, Paul J Zhang, Giulio C Spagnoli, John E Tomaszewski, Theresa L Pasha, Denise Frosina, Otavia L Caballero, Andrew J G Simpson, Lloyd J Old, Achim A Jungbluth.   

Abstract

Cancer/testis (CT) antigens are named after their expression pattern as they are typically present in various types of tumors and in the germ cells of normal adult testis. Adult ovarian tissue is usually reported to be CT antigen negative. Based on the differences in female versus male gonadal development, the ovarian counterpart of the most predominant CT antigen positive testicular germ cells are not prevalent in the adult ovary. Hence, we analyzed the protein expression of several CT antigens in fetal ovary by immunohistochemistry with various monoclonal antibodies (mAbs) previously generated by our group. The mAbs used were: MA454 (MAGE-A1), M3H67 (MAGE-A3), 57B (MAGE-A4), CT7-33 (CT7/MAGE-C1), and ES121 (NY-ESO-1). All mAbs showed some immunopositivity in fetal ovarian germ cells. The most intense staining was seen with mAbs M3H67, 57B, and CT7-33 during weeks 16-23 of gestation. The most prevalent cells stained were oogonia, with only focal staining of oocytes of the primordial follicle. We conclude that CT antigens are regularly expressed in fetal ovarian germ cells and might play an important role in male and female germ cell biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217256      PMCID: PMC3077293     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN: 1424-9634


  32 in total

Review 1.  Differentiation of mammalian embryonic gonad.

Authors:  A G Byskov
Journal:  Physiol Rev       Date:  1986-01       Impact factor: 37.312

2.  A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation.

Authors:  Zoran M Cilensek; Fruma Yehiely; Rupinder K Kular; Louis P Deiss
Journal:  Cancer Biol Ther       Date:  2002 Jul-Aug       Impact factor: 4.742

3.  MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.

Authors:  Martin Monte; Marta Simonatto; Leticia Y Peche; Debora R Bublik; Stefania Gobessi; Marco A Pierotti; Monica Rodolfo; Claudio Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

4.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

5.  The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

Authors:  O Türeci; U Sahin; I Schobert; M Koslowski; H Scmitt; H J Schild; F Stenner; G Seitz; H G Rammensee; M Pfreundschuh
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

6.  New paths in human cancer serology.

Authors:  L J Old; Y T Chen
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

7.  Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.

Authors:  M F Gjerstorff; L E Johansen; O Nielsen; K Kock; H J Ditzel
Journal:  Br J Cancer       Date:  2006-06-19       Impact factor: 7.640

8.  Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

Authors:  A A Jungbluth; E Stockert; Y T Chen; D Kolb; K Iversen; K Coplan; B Williamson; N Altorki; K J Busam; L J Old
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

9.  A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.

Authors:  B Van den Eynde; O Peeters; O De Backer; B Gaugler; S Lucas; T Boon
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.

Authors:  A M Gillespie; S Rodgers; A P Wilson; J Tidy; R C Rees; R E Coleman; A K Murray
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more
  11 in total

1.  Expression of cancer-testis (CT) antigens in placenta.

Authors:  Achim A Jungbluth; Wilson A Silva; Kristin Iversen; Denise Frosina; Bushra Zaidi; Keren Coplan; Susannah K Eastlake-Wade; Sandra B Castelli; Giulio C Spagnoli; Lloyd J Old; Martin Vogel
Journal:  Cancer Immun       Date:  2007-08-24

Review 2.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

3.  The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis.

Authors:  Jennifer Gantchev; Amelia Martínez Villarreal; Scott Gunn; Monique Zetka; Neils Ødum; Ivan V Litvinov
Journal:  Cell Cycle       Date:  2020-03-30       Impact factor: 4.534

4.  MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus.

Authors:  Alice D C Hoftman; Lei-Qian Tai; Sheila Tze; David Seligson; Richard A Gatti; Deborah K McCurdy
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

5.  The expansion of the PRAME gene family in Eutheria.

Authors:  Ti-Cheng Chang; Yang Yang; Hiroshi Yasue; Arvind K Bharti; Ernest F Retzel; Wan-Sheng Liu
Journal:  PLoS One       Date:  2011-02-10       Impact factor: 3.240

6.  An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.

Authors:  Riguel J Inaoka; Achim A Jungbluth; Otávio Cg Baiocchi; Mariane Cg Assis; Nicole C Hanson; Denise Frosina; Jodie Tassello; Adriana B Bortoluzzo; Antonio C Alves; Gisele Wb Colleoni
Journal:  BMC Cancer       Date:  2011-09-28       Impact factor: 4.430

7.  Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.

Authors:  Bret Stephens; Stephen P Anthony; Haiyong Han; Jeffery Kiefer; Galen Hostetter; Michael Barrett; Daniel D Von Hoff
Journal:  J Cancer       Date:  2012-01-26       Impact factor: 4.207

8.  MAGE-A Antigens and Cancer Immunotherapy.

Authors:  Paul Zajac; Elke Schultz-Thater; Luigi Tornillo; Charlotte Sadowski; Emanuele Trella; Chantal Mengus; Giandomenica Iezzi; Giulio C Spagnoli
Journal:  Front Med (Lausanne)       Date:  2017-03-08

9.  Rapid evolution of cancer/testis genes on the X chromosome.

Authors:  Brian J Stevenson; Christian Iseli; Sumir Panji; Monique Zahn-Zabal; Winston Hide; Lloyd J Old; Andrew J Simpson; C Victor Jongeneel
Journal:  BMC Genomics       Date:  2007-05-23       Impact factor: 3.969

10.  Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells.

Authors:  Anna Pagotto; Otavia L Caballero; Norbert Volkmar; Sylvie Devalle; Andrew J G Simpson; Xin Lu; John C Christianson
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.